The store will not work correctly when cookies are disabled.
(2R,3S,4S,5R)-2-((3,4-dichlorophenylamino)methyl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
ID: ALA3220031
PubChem CID: 90666783
Max Phase: Preclinical
Molecular Formula: C12H15Cl2NO4
Molecular Weight: 308.16
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: OC[C@H]1O[C@H](CNc2ccc(Cl)c(Cl)c2)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C12H15Cl2NO4/c13-7-2-1-6(3-8(7)14)15-4-9-11(17)12(18)10(5-16)19-9/h1-3,9-12,15-18H,4-5H2/t9-,10-,11-,12-/m1/s1
Standard InChI Key: CNSOZTCZYCNRHJ-DDHJBXDOSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
10.4941 -2.9020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2709 -2.6615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8303 -2.4032 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.2521 -3.6610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1696 -2.8910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4299 -3.6610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5058 -4.4454 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.3938 -2.6472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1743 -4.4512 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.3691 -1.8326 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.8704 -3.2168 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.6511 -2.9752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2462 -3.5316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0262 -3.2905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2079 -2.4929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6035 -1.9367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8258 -2.1807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6255 -3.8461 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
14.9883 -2.2502 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 6
1 3 1 0
4 1 1 0
3 5 1 0
4 6 1 0
4 7 1 1
5 8 1 1
6 9 1 6
8 10 1 0
6 5 1 0
2 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
14 18 1 0
15 19 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 308.16 | Molecular Weight (Monoisotopic): 307.0378 | AlogP: 0.89 | #Rotatable Bonds: 4 |
Polar Surface Area: 81.95 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.78 | CX Basic pKa: 3.45 | CX LogP: 0.60 | CX LogD: 0.60 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.66 | Np Likeness Score: 0.09 |
References
1. Lavorato SN, Andrade SF, Silva THA, Alves RJ, Oliveira RB. (2012) Phosphofructokinase: structural and functional aspects and design of selective inhibitors, 3 (10): [10.1039/C2MD20122D] |